Clinical Trial Update: Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of lapatinib and vinorelbine in HER2-overexpressing locally advanced or metastatic breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED